Literature DB >> 26315139

Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice.

Gabriele B Beck-Engeser1, Tomasz Ahrends1, Gero Knittel1, Rafael Wabl1, Mirjam Metzner1, Dan Eilat2, Matthias Wabl1.   

Abstract

Murine leukaemia virus has been suggested to contribute to both autoimmune disease and leukaemia in the NZB mouse and in the (NZB × NZW) F1 (abbreviated B/W) mouse. However, with apparently only xenotropic but no ecotropic virus constitutively expressed in these mice, few mechanisms could explain the aetiology of either disease in either mouse strain. Because pseudotyped and/or inducible ecotropic virus may play a role, we surveyed the ability of murine leukaemia virus in NZB, NZW and B/W mice to infect and form a provirus. From the spleen of NZB mice, we isolated circular cDNA of xenotropic and polytropic virus, which indicates ongoing infection by these viruses. From a B/W lymphoma, we isolated and determined the complete sequence of a putative ecotropic NZW virus. From B/W mice, we recovered de novo endogenous retroviral integration sites (tags) from the hyperproliferating cells of the spleen and the peritoneum. The tagged genes seemed to be selected to aid cellular proliferation, as several of them are known cancer genes. The insertions are consistent with the idea that endogenous retrovirus contributes to B-cell hyperproliferation and progression to lymphoma in B/W mice.

Entities:  

Mesh:

Year:  2015        PMID: 26315139      PMCID: PMC4806582          DOI: 10.1099/jgv.0.000271

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  A computational method for prediction of matrix proteins in endogenous retroviruses.

Authors:  Yucheng Ma; Ruiling Liu; Hongqiang Lv; Jiuqiang Han; Dexing Zhong; Xinman Zhang
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 2.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.